ReviewIJID regions2026
Understanding the epidemiological trends and economic impact of dengue in Indonesia: A systematic literature review.
Review in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To identify and analyze evidence on the epidemiological trends and economic impact of dengue in Indonesia. Methods: Electronic databases (PubMed, Embase, and the Cochrane Database) and gray literature were searched for publicly available data on the epidemiological (2000-2020) and economic (2010-2020) dengue burden in Indonesia. Data from the selected studies were extracted and summarized descriptively. An additional search conducted identified country-level dengue studies in Indonesia published in recent years (2021-2024). Results: For epidemiological burden, 143 publications (94 published studies; 49 gray literature articles) were included. The number of reported dengue cases increased, ranging from 21,143 in 2000 to 204,172 in 2016. Incidence rates (IRs) peaked at 78.9 cases per 100,000 population in 2016. Between 2017 and 2020, dengue cases were generally highest among 5-14-year-olds. While the number of deaths has fluctuated since 2000, case fatality rates have declined. Regionally, Bali and East Kalimantan reported some of the highest IRs between 2000 and 2020. Underreporting was widespread, with expansion factors ranging from 1.66 for hospitalized cases to 34.01 for ambulatory cases. Results from eight studies showed that dengue was associated with a significant economic burden, with higher costs for hospitalized/fatal cases than for ambulatory cases. The additional search identified 11 relevant articles; however, none provided country-level primary data on dengue incidence, mortality, serotype distribution, or economic outcomes in Indonesia. Conclusion: Dengue burden in Indonesia is high, with severe cases associated with a significant economic burden.PROSPERO Registration Number: CRD42021266804.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.